Discover
CPHI
China Pharma Holdings, Inc.
0.68
400 x 0.60
700 x 0.74
bid
ask
+
0.02
2.71%
550 @ 06:19 AM
0.71 +0.03 (4.72%)
| Ytd | -43.97% | |
| 1y | -62.54% |
0.63
day range
0.68
0.38
52 week range
2.03
| Open | 0.66 | Prev Close | 0.66 | Low | 0.63 | High | 0.68 | Mkt Cap | 27.47M |
| Vol | 161.04K | Avg Vol | 289.90K | EPS | -0.54 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.71 | Short Ratio | 0.22 | Inst. Own | 0.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 0.71 | 200-d Avg | 1.12 | 1yr Est | 3.00 |
| Income Statement | |||
| Total Revenue | 983.54K | ||
| Revenues (USD) | 983.54K | ||
| Cost of Revenue | 698.05K | ||
| Gross Profit | 285.49K | ||
| Operating Expenses | 1.40M | ||
| Research and Development Expense | 83.76K | ||
| Selling, General and Administrative Expense | 1.32M | ||
| Operating Income | -1.12M | ||
| Interest Expense | 26.03K | ||
| Net Income | -1.14M | ||
| Net Income Common Stock | -1.14M | ||
| Net Income Common Stock (USD) | -1.14M | ||
| Consolidated Income | -1.14M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -1.12M | ||
| Earning Before Interest & Taxes (USD) | -1.12M | ||
| Weighted Average Shares | 25.60M | ||
| Weighted Average Shares Diluted | 25.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 168.47K | ||
| Cash and Equivalents (USD) | 168.47K | ||
| Trade and Non-Trade Receivables | 262.30K | ||
| Current Assets | 2.00M | ||
| Property, Plant & Equipment Net | 4.47M | ||
| Total Assets | 45.14M | ||
| Debt Current | 3.47M | ||
| Total Debt | 3.56M | ||
| Current Liabilities | 7.27M | ||
| Debt Non-Current | 92.29K | ||
| Total Liabilities | 8.12M | ||
| Accumulated Retained Earnings (Deficit) | -48.36M | ||
| Accumulated Other Comprehensive Income | 12.02M | ||
| Shareholders Equity | 37.02M | ||
| Shareholders Equity (USD) | 37.02M | ||
| Assets Non-Current | 43.14M | ||
| Total Debt (USD) | 3.56M | ||
| Deferred Revenue | 61.75K | ||
| Goodwill and Intangible Assets | 38.67M | ||
| Inventory | 1.50M | ||
| Liabilities Non-Current | 851.92K | ||
| Trade and Non-Trade Payables | 3.43M | ||
| Tax Liabilities | 759.63K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 980.57K | ||
| Net Cash Flow from Financing | -79.32K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -176.64K | ||
| Issuance (Repayment) of Debt Securities | -79.32K | ||
| Net Cash Flow from Operations | -55.29K | ||
| Effect of Exchange Rate Changes on Cash | -42.02K | ||